Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
20040110
NCT00089960
2.
Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
20 and over
Pharmaceutical / Industry
20050129
NCT00254267
3.
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
20060136
NCT00369070
Last Modified:
5/8/2008
 
First Published:
12/13/2007
4.
Phase II Study of AMG 706 in Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
GOG-0170L
GOG-0170L, AMGEN-20060747, NCT00574951
5.
Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
Pharmaceutical / Industry
20030116
NCT00093873
Last Modified:
4/27/2007
 
First Published:
5/5/2006
6.
Phase I Study of AMG 706 and Gemcitabine Hydrochloride in Patients With Advanced Solid Tumors or Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-0506055-01
NCT00324597
7.
Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
20060443
NCT00448786
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute